Literature DB >> 19705304

Primary thyroid marginal zone B-cell lymphoma MALT-type in a patient with rheumatoid arthritis.

Songul Serefhanoglu1, Umit Tapan, Ihsan Ertenli, Umut Kalyoncu, Aysegul Uner.   

Abstract

Autoimmune diseases are defined as specific, adapted immune reactions against self antigens. Immune mechanism deficiency is a causal factor for B-cell lymphoma in primary Sjögren's syndrome and autoimmune thyroid disease. Thyroid mucosa-associated lymphoid tissue (MALT) lymphoma is a 67-fold and parotid lymphoma is a 44-fold increased risk in Sjögren's syndrome and thyroiditis. MALT lymphoma was not reported in rheumatoid arthritis. We herein report the case of a 56-year-old woman with maltoma of thyroid in rheumatoid arthritis patient.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19705304     DOI: 10.1007/s12032-009-9293-x

Source DB:  PubMed          Journal:  Med Oncol        ISSN: 1357-0560            Impact factor:   3.064


  19 in total

1.  Primary thyroid lymphoma is a heterogeneous disease.

Authors:  C Thieblemont; A Mayer; C Dumontet; Y Barbier; E Callet-Bauchu; P Felman; F Berger; X Ducottet; C Martin; G Salles; J Orgiazzi; B Coiffier
Journal:  J Clin Endocrinol Metab       Date:  2002-01       Impact factor: 5.958

2.  Haematopoietic malignancies in rheumatoid arthritis: lymphoma risk and characteristics after exposure to tumour necrosis factor antagonists.

Authors:  J Askling; C M Fored; E Baecklund; L Brandt; C Backlin; A Ekbom; C Sundström; L Bertilsson; L Cöster; P Geborek; L T Jacobsson; S Lindblad; J Lysholm; S Rantapää-Dahlqvist; T Saxne; L Klareskog; N Feltelius
Journal:  Ann Rheum Dis       Date:  2005-04-20       Impact factor: 19.103

3.  Mucosa-associated lymphoid tissue lymphomas in two patients with rheumatoid arthritis on second-line agents, and secondary Sjögren's syndrome.

Authors:  N Sutcliffe; C Smith; P M Speight; D A Isenberg
Journal:  Rheumatology (Oxford)       Date:  2000-02       Impact factor: 7.580

4.  [Lung changes during the course of non-Hodgkin's lymphoma in a patient with rhematoid arthritis with secondary Sjogren's syndrome].

Authors:  D Gawryluk; R Langfort; W Suleiman; B Burakowska; E Decker
Journal:  Pneumonol Alergol Pol       Date:  2000

Review 5.  Diagnosis of lymphoma by fine-needle aspiration cytology using the revised European-American classification of lymphoid neoplasms.

Authors:  N A Young; T Al-Saleem
Journal:  Cancer       Date:  1999-12-25       Impact factor: 6.860

6.  Tumour necrosis factor blockers do not increase overall tumour risk in patients with rheumatoid arthritis, but may be associated with an increased risk of lymphomas.

Authors:  P Geborek; A Bladström; C Turesson; A Gulfe; I F Petersson; T Saxne; H Olsson; L T H Jacobsson
Journal:  Ann Rheum Dis       Date:  2005-02-04       Impact factor: 19.103

7.  Clinical aspects of primary thyroid lymphoma: diagnosis and treatment based on our experience of 119 cases.

Authors:  F Matsuzuka; A Miyauchi; S Katayama; I Narabayashi; H Ikeda; K Kuma; M Sugawara
Journal:  Thyroid       Date:  1993       Impact factor: 6.568

Review 8.  Thyroid disease in Sjögren's syndrome.

Authors:  Luis J Jara; Carmen Navarro; María del Pilar Brito-Zerón; Mario García-Carrasco; Ricardo O Escárcega; Manuel Ramos-Casals
Journal:  Clin Rheumatol       Date:  2007-06-09       Impact factor: 2.980

9.  Localized mucosa-associated lymphoid tissue lymphoma treated with radiation therapy has excellent clinical outcome.

Authors:  Richard W Tsang; Mary K Gospodarowicz; Melania Pintilie; Woodrow Wells; David C Hodgson; Alexander Sun; Michael Crump; Bruce J Patterson
Journal:  J Clin Oncol       Date:  2003-11-15       Impact factor: 44.544

Review 10.  [Primary orbital lymphoma within the context of Sjögren's syndrome secondary to rheumatoid arthritis].

Authors:  F Rasquin; J Hamels; M Cordonnier; A Zanen; A Stilmant
Journal:  Bull Soc Belge Ophtalmol       Date:  1994
View more
  1 in total

Review 1.  The Association of Sjögren Syndrome and Autoimmune Thyroid Disorders.

Authors:  Chiara Baldini; Francesco Ferro; Marta Mosca; Poupak Fallahi; Alessandro Antonelli
Journal:  Front Endocrinol (Lausanne)       Date:  2018-04-03       Impact factor: 5.555

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.